(Q43432898)

23 November 2017

Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab (English)

1 reference

23 November 2017

1 reference

A Zeevi

1

1 reference

23 November 2017

S Husain

2

1 reference

23 November 2017

K J Spichty

3

1 reference

23 November 2017

K Raza

4

1 reference

23 November 2017

J B Woodcock

5

1 reference

23 November 2017

D Zaldonis

6

1 reference

23 November 2017

L M Carruth

7

1 reference

23 November 2017

R J Kowalski

8

1 reference

23 November 2017

J A Britz

9

1 reference

23 November 2017

K R McCurry

10

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

American Journal of Transplantation

23 November 2017

1 reference

23 November 2017

7

1 reference

23 November 2017

2

1 reference

23 November 2017

471-475

1 reference

Tolerogenic immunosuppression for organ transplantation

23 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Clinical significance of CMV-specific T helper responses in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Clinical significance of cytomegalovirus-specific T helper responses and cytokine production in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Ganciclovir-resistant cytomegalovirus in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2006.01641.X

10.1111/J.1600-6143.2006.01641.X

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference